Cosmetic octapeptide (Argireline analog)
Acetyl Glutamyl Heptapeptide-3
An extended cosmetic peptide similar to Argireline, designed for expression wrinkle reduction with limited clinical data.
- Evidence:
- Limited human evidence
- Status:
- Not FDA-approved
- Reviewed:
- 2026-08-03
Also known as: Acetyl Glutamyl Heptapeptide-3, Acetyl Octapeptide-3
What is Acetyl Glutamyl Heptapeptide-3?
An extended cosmetic peptide similar to Argireline, designed for expression wrinkle reduction with limited clinical data.
This profile is educational. It organizes publicly discussed research context for Acetyl Glutamyl Heptapeptide-3 and related naming aliases — it is not a treatment guide.
Proposed mechanism
SNARE complex modulation reducing neurotransmitter release at motor endplates, attenuating dynamic wrinkles.
Mechanism language on PepGuide describes how researchers discuss pathways. Proposed mechanisms can change as evidence evolves.
Current research notes
Human evidence grade: Limited human evidence
Preclinical evidence grade: Early-stage human research
Snap-8 is marketed as a more potent Argireline analog. Evidence base is primarily in vitro and small manufacturer-sponsored cosmetic studies. Human evidence remains limited. Used in topical anti-aging products.
Key uncertainties
- Superiority over pentapeptide-4 or hexapeptide-8
Research areas being studied
- Expression wrinkles
- Cosmetic peptides
Being studied for a topic is not the same as proven benefit in that topic. Prefer primary literature for study design, endpoints, and limitations.
Safety & side-effect notes
Reported or discussed adverse effects
- Topical tolerance generally good
Additional risks & considerations
- Limited independent clinical trials
- Modest expected effects
Regulatory status
Not FDA-approved
Cosmetic ingredient.
Regulatory framing here is educational and can lag policy changes. Check official sources for current status.
Frequently asked questions
What is Acetyl Glutamyl Heptapeptide-3?
An extended cosmetic peptide similar to Argireline, designed for expression wrinkle reduction with limited clinical data.
How does Acetyl Glutamyl Heptapeptide-3 work (proposed mechanism)?
SNARE complex modulation reducing neurotransmitter release at motor endplates, attenuating dynamic wrinkles.
What is Acetyl Glutamyl Heptapeptide-3 being researched for?
Acetyl Glutamyl Heptapeptide-3 has been discussed in research contexts including: Expression wrinkles, Cosmetic peptides.
What does current evidence say about Acetyl Glutamyl Heptapeptide-3?
Limited human evidence. Snap-8 is marketed as a more potent Argireline analog. Evidence base is primarily in vitro and small manufacturer-sponsored cosmetic studies. Human evidence remains limited. Used in topical anti-aging products.
What safety considerations are noted for Acetyl Glutamyl Heptapeptide-3?
Reported or discussed considerations include: Topical tolerance generally good; Limited independent clinical trials; Modest expected effects. This is educational information, not medical advice.
References & sources
- Manufacturer research summaries (2010). Octapeptide SNARE modulators in cosmetic research. Evidence type: in_vitro.
Prefer interactive tools? Open the PepGuide library entry for Acetyl Glutamyl Heptapeptide-3 or ask PepGuide AI.
Educational and research information only. PepGuide does not sell or prescribe peptides, diagnose conditions, or provide personalized medical advice. Evidence summaries may include early-stage, animal, or limited human research — none of that is a substitute for primary literature or clinician guidance.